UFP Technologies Inc income statement
In fiscal 2025, UFP Technologies Inc reported revenue of $603m, up 19.5% on the year before, operating income of $92.3m (a 15.3% margin) and net income of $68.3m, or $8.75 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99 | 121 | 127 | 131 | 139 | 139 | 139 | 146 | 148 | 190 | 198 | 179 | 206 | 354 | 400 | 504 | 603 | 632 |
| Cost of revenue | — | — | — | — | — | — | — | 111 | 112 | 142 | 144 | 135 | 155 | 264 | 288 | 358 | 432 | 452 |
| Gross profit | 27 | 35 | 36 | 38 | 41 | 37 | 37 | 35 | 35 | 48 | 54 | 45 | 51 | 90 | 112 | 147 | 170 | 180 |
| Research and development | — | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 11 | 9 | 8 | 9 | 9 | 7 | 10 | 9 | — |
| Selling, general and administrative | 19 | 20 | 21 | 22 | 24 | 24 | 24 | 24 | 24 | 28 | 29 | 27 | 29 | 46 | 51 | 62 | 77 | 84 |
| Operating income | 8 | 14 | 16 | 17 | 17 | 12 | 12 | 12 | 12 | 20 | 25 | 17 | 21 | 55 | 58 | 81 | 92 | 96 |
| Interest expense | — | — | — | — | — | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 4 | 8 | 10 | 8 |
| Net interest income | −0 | −0 | −0 | −0 | −0 | −0 | 0 | — | — | — | — | — | — | — | — | — | — | — |
| Income before tax | 9 | 14 | 16 | 17 | 17 | 12 | 12 | 12 | 12 | 18 | 24 | 16 | 21 | 53 | 54 | 73 | 83 | 89 |
| Income tax | 3 | 5 | 5 | 6 | 6 | 4 | 4 | 4 | 3 | 4 | 4 | 3 | 5 | 11 | 9 | 14 | 14 | 16 |
| Net income | 6 | 9 | 10 | 11 | 11 | 8 | 8 | 8 | 9 | 14 | 20 | 13 | 16 | 42 | 45 | 59 | 68 | 72 |
| Diluted EPS | $0.94 | $1.37 | $1.48 | $1.55 | $1.59 | $1.05 | $1.05 | $1.10 | $1.26 | $1.93 | $2.63 | $1.77 | $2.09 | $5.45 | $5.83 | $7.58 | $8.75 | $9.25 |
| Diluted shares (average) | 6m | 7m | 7m | 7m | 7m | 7m | 7m | 7m | 7m | 7m | 8m | 8m | 8m | 8m | 8m | 8m | 8m | 8m |
| EBITDA | 11 | 18 | 18 | 20 | 21 | 16 | 17 | 18 | 17 | 27 | 33 | 25 | 30 | 67 | 69 | 96 | 111 | 111 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 145 | 144 | 148 | 151 | 155 | 149 | 154 | 174 |
| Cost of revenue | 104 | 102 | 106 | 108 | 112 | 107 | 110 | 123 |
| Gross profit | 42 | 42 | 42 | 44 | 43 | 42 | 44 | 51 |
| Selling, general and administrative | 16 | 19 | 19 | 19 | 19 | 21 | 21 | 23 |
| Operating income | 25 | 22 | 23 | 24 | 23 | 22 | 23 | 28 |
| Interest expense | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Income before tax | 21 | 19 | 20 | 22 | 21 | 20 | 22 | 26 |
| Income tax | 5 | 3 | 3 | 4 | 5 | 2 | 4 | 6 |
| Net income | 16 | 16 | 17 | 17 | 16 | 18 | 17 | 21 |
| Diluted EPS | $2.11 | $2.10 | $2.21 | $2.21 | $2.11 | $2.25 | $2.24 | $2.68 |
| EBITDA | 29 | 27 | 28 | 29 | 21 | 34 | 26 | 31 |
Compare with peers
- Organogenesis Holdings Inc. income statement
- Embecta Corp. income statement
- Mimedx Group, Inc. income statement
- ICU Medical Inc income statement
- Envista Holdings Corp income statement
Head to head: ORGO vs UFPTEMBC vs UFPTMDXG vs UFPT
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies